Royal Bank of Canada’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.84M | Buy |
60,103
+2,303
| +4% | +$118K | ﹤0.01% | 3038 |
|
|
2026
Q1 | $3.43M | Buy |
57,800
+5,265
| +10% | +$342K | ﹤0.01% | 2697 |
|
|
2025
Q4 | $3.24M | Buy |
52,535
+5,317
| +11% | +$325K | ﹤0.01% | 2776 |
|
|
2025
Q3 | $2.95M | Sell |
47,218
-7,236
| -13% | -$504K | ﹤0.01% | 3093 |
|
|
2025
Q2 | $4.35M | Buy |
54,454
+15,705
| +41% | +$1.31M | ﹤0.01% | 2681 |
|
|
2025
Q1 | $3.33M | Sell |
38,749
-109
| -0.3% | -$8.94K | ﹤0.01% | 2569 |
|
|
2024
Q4 | $3.03M | Buy |
38,858
+3,400
| +10% | +$264K | ﹤0.01% | 2704 |
|
|
2024
Q3 | $2.56M | Buy |
35,458
+673
| +2% | +$47.7K | ﹤0.01% | 2809 |
|
|
2024
Q2 | $2.4M | Buy |
34,785
+5,675
| +19% | +$384K | ﹤0.01% | 2773 |
|
|
2024
Q1 | $2.11M | Sell |
29,110
-12,113
| -29% | -$810K | ﹤0.01% | 2876 |
|
|
2023
Q4 | $2.52M | Sell |
41,223
-1,720
| -4% | -$102K | ﹤0.01% | 2856 |
|
|
2023
Q3 | $2.46M | Buy |
42,943
+4,511
| +12% | +$273K | ﹤0.01% | 2680 |
|
|
2023
Q2 | $2.29M | Buy |
38,432
+10,012
| +35% | +$599K | ﹤0.01% | 2732 |
|
|
2023
Q1 | $1.78M | Buy |
28,420
+10,286
| +57% | +$642K | ﹤0.01% | 2888 |
|
|
2022
Q4 | $1.14M | Sell |
18,134
-465,090
| -96% | -$26.7M | ﹤0.01% | 3396 |
|
|
2022
Q3 | $24.1M | Sell |
483,224
-22,208
| -4% | -$1.23M | 0.01% | 966 |
|
|
2022
Q2 | $29.7M | Sell |
505,432
-4,879
| -1% | -$269K | 0.01% | 888 |
|
|
2022
Q1 | $27M | Sell |
510,311
-506,707
| -50% | -$29.3M | 0.01% | 1060 |
|
|
2021
Q4 | $61.7M | Sell |
1,017,018
-28,206
| -3% | -$1.67M | 0.01% | 726 |
|
|
2021
Q3 | $58.6M | Sell |
1,045,224
-37,327
| -3% | -$2.05M | 0.02% | 679 |
|
|
2021
Q2 | $56.4M | Sell |
1,082,551
-54,619
| -5% | -$2.62M | 0.02% | 690 |
|
|
2021
Q1 | $50.1M | Sell |
1,137,170
-44,333
| -4% | -$1.86M | 0.01% | 702 |
|
|
2020
Q4 | $41.2M | Sell |
1,181,503
-9,425
| -0.8% | -$335K | 0.01% | 789 |
|
|
2020
Q3 | $43.4M | Sell |
1,190,928
-25,824
| -2% | -$960K | 0.02% | 680 |
|
|
2020
Q2 | $45.7M | Buy |
1,216,752
+52,190
| +4% | +$2.09M | 0.02% | 612 |
|
|
2020
Q1 | $42.7M | Sell |
1,164,562
-151,891
| -12% | -$5.9M | 0.02% | 548 |
|
|
2019
Q4 | $53.3M | Buy |
1,316,453
+3,564
| +0.3% | +$133K | 0.02% | 602 |
|
|
2019
Q3 | $45.5M | Buy |
1,312,889
+55,298
| +4% | +$1.82M | 0.02% | 631 |
|
|
2019
Q2 | $39.8M | Buy |
1,257,591
+154,586
| +14% | +$4.59M | 0.02% | 686 |
|
|
2019
Q1 | $33M | Sell |
1,103,005
-47,395
| -4% | -$1.36M | 0.01% | 760 |
|
|
2018
Q4 | $35.5M | Sell |
1,150,400
-100,833
| -8% | -$3.68M | 0.02% | 672 |
|
|
2018
Q3 | $47.4M | Sell |
1,251,233
-73,217
| -6% | -$2.77M | 0.02% | 609 |
|
|
2018
Q2 | $50.8M | Sell |
1,324,450
-702,877
| -35% | -$23.7M | 0.02% | 557 |
|
|
2018
Q1 | $68.4M | Buy |
2,027,327
+909,507
| +81% | +$34.9M | 0.03% | 457 |
|
|
2017
Q4 | $49.6M | Buy |
1,117,820
+526,049
| +89% | +$24M | 0.02% | 608 |
|
|
2017
Q3 | $29.6M | Buy |
591,771
+52,665
| +10% | +$2.69M | 0.01% | 832 |
|
|
2017
Q2 | $28.5M | Buy |
539,106
+114,101
| +27% | +$6.11M | 0.01% | 832 |
|
|
2017
Q1 | $23.6M | Buy |
425,005
+10,029
| +2% | +$553K | 0.01% | 922 |
|
|
2016
Q4 | $21.6M | Buy |
414,976
+404,109
| +3,719% | +$19.5M | 0.01% | 1016 |
|
|
2016
Q3 | $525K | Sell |
10,867
-1,032
| -9% | -$52.2K | ﹤0.01% | 3669 |
|
|
2016
Q2 | $659K | Sell |
11,899
-6,117
| -34% | -$337K | ﹤0.01% | 3452 |
|
|
2016
Q1 | $963K | Buy |
18,016
+8,406
| +87% | +$414K | ﹤0.01% | 3091 |
|
|
2015
Q4 | $495K | Buy |
9,610
+7,663
| +394% | +$381K | ﹤0.01% | 3782 |
|
|
2015
Q3 | $88K | Buy |
1,947
+401
| +26% | +$18.9K | ﹤0.01% | 4839 |
|
|
2015
Q2 | $71K | Sell |
1,546
-3,858
| -71% | -$169K | ﹤0.01% | 5030 |
|
|
2015
Q1 | $232K | Sell |
5,404
-723
| -12% | -$27.6K | ﹤0.01% | 4127 |
|
|
2014
Q4 | $213K | Buy |
6,127
+1,191
| +24% | +$39.5K | ﹤0.01% | 4295 |
|
|
2014
Q3 | $160K | Sell |
4,936
-75
| -1% | -$2.51K | ﹤0.01% | 4340 |
|
|
2014
Q2 | $170K | Buy |
+5,011
| New | +$161K | ﹤0.01% | 4273 |
|
|
2014
Q1 | – | Sell |
-898
| Closed | -$32K | – | 6079 |
|
|
2013
Q4 | $32K | Sell |
898
-43,545
| -98% | -$1.45M | ﹤0.01% | 5068 |
|
|
2013
Q3 | $1.34M | Buy |
44,443
+9,532
| +27% | +$312K | ﹤0.01% | 2508 |
|
|
2013
Q2 | $1.02M | Buy |
+34,911
| New | +$984K | ﹤0.01% | 2560 |
|
Other funds holding PBH
AI
BIP
Royal Bank of Canada's PBH Position: Q2 2026 in Review
Royal Bank of Canada increased its Prestige Consumer Healthcare (PBH) stake by 4% in Q2 2026, buying an estimated $118K and bringing the position to 60,103 shares worth $2.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3038.
Royal Bank of Canada first reported a position in PBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $68.4M in Q1 2018. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Royal Bank of Canada held 60,103 shares of Prestige Consumer Healthcare worth $2.84M as of Q2 2026.
- Royal Bank of Canada bought 2,303 Prestige Consumer Healthcare shares in Q2 2026, an estimated $118K.
- Prestige Consumer Healthcare made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #3038 holding.
- Royal Bank of Canada first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Prestige Consumer Healthcare position peaked at $68.4M in Q1 2018.
- 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.